Feedback / Questions
Yervoy (ipilimumab) - BMS
ABP 206 (nivolumab biosimilar) - Amgen
Opdivo (nivolumab) - BMS
Cdactin-O (CBM588) - Osel, Miyarisan
nivolumab biosimilar (BCD-263) - Biocad
http://clinicaltrials.gov/ct2/show/NCT06399419
May 3, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next